Nicoretteicy (Nicotine)

Nicotine, the active ingredient in Nicoretteicy, is a nicotine replacement therapy presented as an oromucosal product for oral use. It helps adult smokers manage nicotine withdrawal symptoms and cravings as part of a quit‑smoking plan.

GNH USA supplies Nicoretteicy as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed under strict quality‑assurance protocols. Our global network ensures reliable delivery to healthcare providers across multiple regions.

Nicoretteicy is used in nicotine replacement therapy to support smoking cessation.

- Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms when used as part of a quit‑smoking plan.

Nicoretteicy may cause a range of oral and systemic reactions, which are categorized by frequency and severity.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness. - Hiccups: brief, involuntary diaphragm spasms. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate tension‑type pain. - Throat soreness: irritation after use.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: may indicate cardiovascular strain. - Irregular heartbeat: palpitations or arrhythmia. - Severe oral ulceration: persistent sores in the mouth. - Hypertensive crisis: sudden, severe increase in blood pressure.

When considering Nicoretteicy, healthcare professionals should evaluate several safety aspects.

- Cardiovascular assessment: patients with recent myocardial infarction should seek medical advice before use. - Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks. - Age restriction: intended for adult smokers aged 18 years and older. - Concomitant nicotine products: avoid using multiple nicotine sources simultaneously. - Storage: Store at ambient temperature below 25 °C: keep in original packaging, protect from moisture and direct sunlight.

Nicotine can influence the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive response. - Beta‑blockers: nicotine‑induced tachycardia may be masked, complicating cardiovascular monitoring. - CYP2A6 inhibitors: can raise nicotine plasma levels, enhancing side‑effects.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): monitor for increased nausea. - Antihypertensive agents: observe blood pressure for potential fluctuations.